Glenmark to divest majority stake in Glenmark Life Sciences to Nirma
Nirma will acquire 75 per cent stake in Glenmark Life Sciences at a price of Rs 615/- per share
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Novo Nordisk to acquire Inversago Pharma for up to $1.075 bn
The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist
Sigachi Industries forays into API business, acquires majority stake in Trimax Bio Sciences
The API unit is approved by USFDA for advanced and critical intermediates
Novartis acquires DTx Pharma
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two…
Glenmark, Cediprof partner to alleviate US amphetamine shortage
Announce exclusive US distribution pact, distribution expected to start during the second half of 2023
Redx, Jounce announce recommended business combination
Combined group will have a strong clinical pipeline and proven expertise in the discovery and development of highly selective…
Control Print, V Shapes announce JV for sustainable packaging solutions in India
This JV will produce recyclable/biodegradable single-use packets for a wide range of products including liquids, viscous and…
Sun Pharma acquires Disperzyme and Phlogam brands to strengthen its anti-inflammatory portfolio
Disperzyme and Phlogam are fixed-dose combinations of proteolytic enzymes and bioflavonoid viz Tryspin, Bromelain and Rutoside…
Prochem joins hands with Tapasya
The new business entity, Prochem Tapasya, will add value to create a one-stop solution for pharma and allied industries
Sun Pharma to acquire Concert Pharma
Under the terms of the merger agreement, Sun Pharma will promptly commence a tender offer to acquire all outstanding shares of…
Quantumzyme and BEC Chemicals collaborate for green chemistry development
The agreement grants both parties access to each other’s knowledge and expertise to develop novel solutions for Active…
BioNTech buys InstaDeep
BioNTech is to pay 362 million pounds upfront, in a mix of cash and an unspecified number of BioNTech shares, and up to 200…
WuXi Biologics and GSK enter into licence agreement on multiple T Cell Engagers
WuXi Biologics will receive a $40 million upfront payment and up to $1.46 billion in additional payments for research,…
Granules partners with Greenko ZeroC to enable carbon-free energy and green molecule
Granules and Greenko ZeroC will develop and promote state-of-the-art Integrated Green Pharmaceutical Zones (IGPZs) with first…
Cipla and Ethris partner to develop mRNA-based therapies
A collaboration agreement is signed concurrently with the definitive agreement, which paves a path to market Ethris’s innovative…
Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2…
The disease generally has low mortality rate up to six per cent, but can increase significantly in the presence of other…
Zeon Lifesciences collaborates with Vitonnix
The collaboration intends to introduce a sublingual spray to meet the daily nutritional needs
Parexel teams with MyEyeDr to increase patient access and participation in ophthalmology clinical…
Parexel and MyEyeDr are currently collaborating on recruitment for a diabetic retinopathy clinical trial with future plans to…
BSV to acquire Firstline Pharma and Genomicks
Following the acquisition, the two companies will be held by BSV
JB Pharma to acquire the Razel franchise for Rs 314 crore
The acquisition marks JB Pharma’s entry into 'statin’ segment which is the largest group in the cardiac therapy